Pelvic Floor Muscle Training for Women with Myotonic Dystrophy

Key facts

Sponsor

Université de Sherbrooke

Intervention

Pelvic floor muscle training(behavioral)

Enrollment

12 enrolled

Eligibility

18 years · FEMALE

Timeline

2024 – 2026

Study locations (1)

• Clinique des maladies neuromusculaires, Jonquière, Quebec, Canada

Collaborators

Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Interdisciplinary research team on neuromuscular diseases (GRIMN) · CIUSSS Saguenay-Lac-Saint-Jean

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Myotonic dystrophy

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07486934
  Efficacy, Safety, and Tolerability of DYNE-101 in Participants With Myotonic Dystrophy Type 1
  Dyne Therapeutics
• RECRUITINGPHASE2NCT07220603
  An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
  PepGen Inc
• ACTIVE NOT RECRUITINGNCT07493525
  Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1
  Antalya Training and Research Hospital
• RECRUITINGNCT06747884
  Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
  Virginia Commonwealth University
• RECRUITINGNCT07385443
  The Spanish National Registry for Myotonic Dystrophy Type 1
  Fundació Institut Germans Trias i Pujol
• RECRUITINGNCT07362875
  Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy
  Wake Forest University Health Sciences
• RECRUITINGNANCT06809049
  Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)
  Hanns Lochmuller
• RECRUITINGPHASE2NCT06667453
  A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
  PepGen Inc

See all trials for Myotonic dystrophy →